跳至主要内容
临床试验/IRCT20130917014693N12
IRCT20130917014693N12招募中3 期

Investigation of pharmacokinetic and clinical outcomes of various meropenem regimens in patients with ventilator-associated pneumonia and augmented renal clearance

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Definitive or probable diagnosis of VAP based upon CPIS
  • Patients with high probability for ARC according to ARC scoring systems. (score>7)
  • Patients receiving meropenem
  • Patient`s serum creatinine level less than 1.3 mg/dL
  • Patients >18 years old

排除标准

  • Patients sensitive to meropenem
  • Infection due to gram-positive bacteria
  • Patients diagnosed with acute kidney injury
  • Patients non-responsive to meropenem during the first 7 days of treatment and therefore needing medication change

研究者

相似试验